Detalhe da pesquisa
1.
Long-molecule scars of backup DNA repair in BRCA1- and BRCA2-deficient cancers.
Nature
; 621(7977): 129-137, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37587346
2.
Epigenetic dysregulation from chromosomal transit in micronuclei.
Nature
; 619(7968): 176-183, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37286593
3.
Fundamental immune-oncogenicity trade-offs define driver mutation fitness.
Nature
; 606(7912): 172-179, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35545680
4.
Single-cell genomic variation induced by mutational processes in cancer.
Nature
; 612(7938): 106-115, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36289342
5.
Diverse alterations associated with resistance to KRAS(G12C) inhibition.
Nature
; 599(7886): 679-683, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34759319
6.
Decreased HER2 expression in endometrial cancer following anti-HER2 therapy.
J Pathol
; 262(2): 129-136, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38013631
7.
A tale of two pathways: Review of immune checkpoint inhibitors in DNA mismatch repair-deficient and microsatellite instability-high endometrial cancers.
Cancer
; 130(10): 1733-1746, 2024 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38422006
8.
Pathogenic germline variants in patients with endometrial cancer of diverse ancestry.
Cancer
; 130(4): 576-587, 2024 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37886874
9.
Nonlobular Invasive Breast Carcinomas with Biallelic Pathogenic CDH1 Somatic Alterations: A Histologic, Immunophenotypic, and Genomic Characterization.
Mod Pathol
; 37(2): 100375, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37925055
10.
Adenoid cystic carcinoma of the Bartholin's gland is underpinned by MYB- and MYBL1- rearrangements.
Gynecol Oncol
; 185: 58-67, 2024 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38368814
11.
Mesonephric and mesonephric-like adenocarcinomas of gynecologic origin: A single-center experience with molecular characterization, treatment, and oncologic outcomes.
Gynecol Oncol
; 182: 32-38, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38246044
12.
Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival.
Gynecol Oncol
; 180: 35-43, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38041901
13.
Mainstreaming in parallel with ovarian cancer tumor testing to improve genetic testing uptake.
Gynecol Oncol
; 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38493020
14.
Moving into the modern era of molecular classification for endometrial cancer.
J Surg Oncol
; 129(1): 120-125, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38100711
15.
Molecular and pathologic data to guide selection of patients with endometrioid endometrial cancer for ovarian preservation.
Int J Gynecol Cancer
; 34(5): 697-704, 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38508587
16.
NR4A3 Expression Is Consistently Absent in Acinic Cell Carcinomas of the Breast: A Potential Nosologic Shift.
Mod Pathol
; 36(6): 100144, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36828363
17.
DNA Methylation Signature of Synchronous Endometrioid Endometrial and Ovarian Carcinomas.
Mod Pathol
; 36(11): 100321, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37652400
18.
HER2 Genetic Intratumor Heterogeneity Is Associated With Resistance to Trastuzumab and Trastuzumab Emtansine Therapy in Recurrent High-Grade Endometrial Cancer.
Mod Pathol
; 36(11): 100299, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37558129
19.
Impact of immune infiltration signatures on prognosis in endometrial carcinoma is dependent on the underlying molecular subtype.
Gynecol Oncol
; 171: 15-22, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36804617
20.
Landscape of chromatin remodeling gene alterations in endometrial carcinoma.
Gynecol Oncol
; 172: 54-64, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36958196